| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |